MedTrace Logo

Efficacy of Statins In Prevention of CIN

NCT01071993 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2017-12-04

Study results available
· View outcomes & findings →

Summary

To determine if statin therapy plus intravenous normal saline, in patients with chronic renal insufficiency undergoing angiography, is superior to placebo plus intravenous normal saline therapy in the prevention of CIN.

Conditions

  • Nephropathy

Interventions

DRUG

placebo

pre-treatment with placebo (80 mg 12 hours prior to the procedure and 40 mg pre-procedure)

DRUG

atorvastatin

pre-treatment with atorvastatin (80 mg 12 hours prior to the procedure and 40 mg pre-procedure)

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Mazen Abu-Fadel, M.D. · Oklahoma Univeristy Health Science Center and VA Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01071993 on ClinicalTrials.gov